Return to article list


RAYNHAM, MA – Sept. 14, 2011 – As part of National Brain Aneurysm Awareness Month, Codman & Shurtleff, Inc. (Codman), a global neurovascular and neuroscience company, is teaming up with the Brain Aneurysm Foundation to host a public education symposium, “What You Want to Know About Brain Aneurysm Treatment & Recovery,” at the DePuy Institute, LLC, the company’s research and education facility.

The free symposium will be held today from 6 p.m. to 9 p.m. and feature a discussion led by Christopher Ogilvy, MD, director of Neurosurgery at Massachusetts General Hospital and Ken Snyder, MD, Assistant Professor of Neurosurgery, Radiology, and Neurology at the University of Buffalo. To register, contact the Brain Aneurysm Foundation at .

“A brain aneurysm can affect anyone so it’s important for the public to understand risk factors, early detection and treatment,” said Dr. Ogilvy, who is executive director of the Brain Aneurysm Foundation's Medical Advisory Board. “Early detection can save lives.”

According to the Brain Aneurysm Foundation, about 1 in 50 or 6 million Americans have an unruptured brain aneurysm and of that about 27,000 of them will rupture, which can lead to brain damage, stroke, or death. A brain aneurysm is a bulging, weak area in the wall of an artery that supplies blood to the brain. In most cases, an unruptured brain aneurysm, which can occur at any age, causes no symptoms and goes unnoticed.

“Codman is pleased to participate in National Brain Aneurysm Awareness Month and support programs that promote better understanding of brain aneurysms and stroke in our own community,” said P. Laxmin Laxminarain, Worldwide President of Codman. “At the same time, we are working hard as a company to develop new interventional treatments that advance the care of patients afflicted with these conditions throughout the world.”

Recognizing the importance of neurovascular care, Codman has expanded its product portfolio and increased its professional education offerings in neurovascular treatment over the last few years. In 2009, it formed Codman Neurovascular, a business unit dedicated to stroke prevention and management. In late 2010, Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for brain aneurysms and hemorrhagic and ischemic stroke, was acquired and became a part of Codman Neurovascular.

Brain Aneurysm Risk Factors

Health professionals believe a number of risk factors contribute to the formation of brain aneurysms, including smoking, hypertension, drug use, infection, tumors, traumatic head injury and a family history of aneurysms. Avoiding or managing these risk factors may decrease the potential of having a brain aneurysm. About the Brain Aneurysm Foundation

The Brain Aneurysm Foundation was established in Boston, MA on August 19, 1994 as a public charity. The Brain Aneurysm Foundation is the nation’s only nonprofit organization solely dedicated to providing critical awareness, education, support and research funding to reduce the incidence of brain aneurysm ruptures. The organization also provides education materials and awareness information to health care professionals and the general population, as well as providing support for patients and their loved ones. For more information, visit:

About Codman & Shurtleff, Inc.

Codman is a global neuroscience and neurovascular company that develops and markets a wide range of products and solutions for the diagnosis and treatment of neurological disorders including chronic pain management, adult and pediatric hydrocephalus, neuro critical care, stroke prevention and management. Codman is part of the DePuy Family of Companies within Johnson & Johnson. The DePuy Family of Companies has a rich heritage of pioneering a broad range of products and solutions across the continuum of orthopaedic and neurological care.

Filed under: Tagged: